20
Evonik Rexim (nanning) Pharmaceutical Co Ltd, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
One of their notable products is GLYCINE, with a corresponding US DMF Number 30393.
Remarkably, this DMF maintains an Active status since its submission on March 02, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 31, 2017, and payment made on December 27, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II